Endo International plc (NASDAQ: ENDP) (TSX: ENL) is a global specialty pharmaceutical company focused on improving patients' lives while creating shareholder value. Endo develops, manufactures, markets and distributes quality branded and generic pharmaceutical products as well as over-the-counter medications though its operating companies. Endo has global headquarters in Dublin, Ireland…More, and U.S. headquarters in Malvern, PA.
REPORT RATINGS
4.8 / 5.0 (110)
Endo International reports have an aggregate usefulness score of 4.8 based on 110 reviews.